M. Hartgers

E-mail and photographs: a case report of a patient-initiated diagnostic tool in the era of electronic communication.

A. Jatoi, M. Hartgers, 2010, Journal of palliative medicine.

Bolus 5‐fluorouracil (5‐FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5‐FU or Capecitabine

A. Grothey, T. Halfdanarson, R. Lobo, 2019, Clinical colorectal cancer.

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.

Minetta C. Liu, M. Borad, T. Bekaii-Saab, 2019, The oncologist.

Capecitabine and temozolomide: design, implementation, and preliminary outcomes from a pilot project to ensure safe prescribing of oral chemotherapy.

R. McWilliams, A. Jatoi, M. Hartgers, 2010, Journal of oncology practice.

Importance of device evaluation for point-of-care prothrombin time international normalized ratio testing programs.

R. Chaudhry, R. McBane, M. Hartgers, 2005, Mayo Clinic proceedings.

Solid Pseudopapillary Neoplasms of the Pancreas: A Large American Cohort.

T. Smyrk, S. Alberts, R. McWilliams, 2019, Pancreas.

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience.

D. Nagorney, T. Smyrk, S. Alberts, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Malignant transformation of biliary adenofibroma: a rare biliary cystic tumor.

S. Venkatesh, T. Smyrk, R. Smoot, 2016, Journal of Gastrointestinal Oncology.

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma

M. Borad, N. Foster, S. Alberts, 2023, The oncologist.